{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T06:05:16Z","timestamp":1780380316930,"version":"3.54.1"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014807","name":"Nagoya University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nucl. Med."],"abstract":"\n Introduction<\/jats:title>\n \n Anti-1-amino-3-[\n 18<\/jats:sup>\n F] fluorocyclobutane-1-carboxylic acid (\n 18<\/jats:sup>\n F-fluciclovine; anti-3-[\n 18<\/jats:sup>\n F] FACBC) is an amino acid positron emission tomography (PET) tracer used for the evaluation of brain tumors in cases of suspected or diagnosed glioma. While its uptake characteristics in brain tumors have been reported, systematic data on background uptake in normal-appearing head tissues including extracranial structures remain limited. The purpose of this study was to characterize the background uptake of\n 18<\/jats:sup>\n F-fluciclovine in intracranial and extracranial head tissues in patients with suspected malignant glioma.\n <\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n 18<\/jats:sup>\n F-fluciclovine PET\/CT images from 20 patients with suspected malignant glioma were retrospectively analyzed. Standardized uptake values (SUVs) were measured in 24 predefined head regions, and inter-regional differences were assessed using one-way ANOVA with Tukey's HSD\n post hoc<\/jats:italic>\n test. Time\u2013activity curves were generated in 15 patients for dynamic evaluation of temporal uptake patterns. In the overall cohort, 8 patients also underwent\n 11<\/jats:sup>\n C-methionine PET\/CT, and SUVs were compared using paired t-tests and their correlations were assessed using Pearson's correlation coefficient. Statistical significance was set at\n P<\/jats:italic>\n \u2009&lt;\u20090.05.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n 18<\/jats:sup>\n F-fluciclovine uptake in the cerebral hemispheres was generally low, with the lowest SUV\n mean<\/jats:sub>\n observed in white matter (0.15\u2009\u00b1\u20090.04). Cortical uptake was uniformly low, with SUV\n mean<\/jats:sub>\n and SUV\n peak<\/jats:sub>\n of 0.28\u2009\u00b1\u20090.06 and 0.31\u2009\u00b1\u20090.07, respectively, and no significant interlobar differences. Among other brain regions, SUV\n mean<\/jats:sub>\n was highest in the cerebellar vermis (0.46\u2009\u00b1\u20090.09), followed by the pons, cerebellum, thalamus\/basal ganglia, midbrain, and medulla. Dynamic imaging demonstrated low and stable brain uptake, whereas the pituitary and parotid glands exhibited early peak uptake followed by washout. In patients who also underwent\n 11<\/jats:sup>\n C-methionine PET,\n 11<\/jats:sup>\n C-methionine showed significantly higher uptake in all brain regions, whereas\n 18<\/jats:sup>\n F-fluciclovine was higher in venous structures, skeletal muscle, and the nasal cavity.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n \n This study establishes a detailed baseline of background\n 18<\/jats:sup>\n F-fluciclovine uptake in normal-appearing intracranial and extracranial head tissues in patients with suspected glioma. These findings may facilitate the distinction between physiological and pathological uptake and inform the interpretation of\n 18<\/jats:sup>\n F-fluciclovine PET in the assessment of brain tumors.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fnume.2026.1850254","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:42:44Z","timestamp":1780378964000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Physiological biodistribution of 18F-fluciclovine PET in the head: as a baseline for interpretation in patients with suspected glioma"],"prefix":"10.3389","volume":"6","author":[{"given":"Yumi","family":"Abe","sequence":"first","affiliation":[{"name":"Department of Radiology, Nagoya University Graduate School of Medicine","place":["Nagoya, Aichi, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryogo","family":"Minamimoto","sequence":"additional","affiliation":[{"name":"Department of Integrated Image Information Analysis, Nagoya University Graduate School of Medicine","place":["Nagoya, Aichi, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotoshi","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Radiological Technology, Nagoya University Hospital","place":["Nagoya, Aichi, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Higashi","sequence":"additional","affiliation":[{"name":"Department of Radiology, Nagoya University Graduate School of Medicine","place":["Nagoya, Aichi, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rintaro","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Radiology, Nagoya University Graduate School of Medicine","place":["Nagoya, Aichi, Japan"]},{"name":"Department of Innovative BioMedical Visualization (iBMV), Nagoya University Graduate School of Medicine","place":["Nagoya, Aichi, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Radiology, Nagoya University Graduate School of Medicine","place":["Nagoya, Aichi, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Deguchi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nagoya University Graduate School of Medicine","place":["Nagoya, Aichi, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiharu","family":"Ohka","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nagoya University Graduate School of Medicine","place":["Nagoya, Aichi, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuta","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nagoya University Graduate School of Medicine","place":["Nagoya, Aichi, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Naganawa","sequence":"additional","affiliation":[{"name":"Department of Radiology, Nagoya University Graduate School of Medicine","place":["Nagoya, Aichi, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.2967\/jnumed.114.143628","article-title":"Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease","volume":"55","author":"Schuster","year":"2014","journal-title":"J Nucl Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.3390\/diagnostics13243610","article-title":"Diagnostic accuracy of PET with 18F-fluciclovine ([18F] FACBC) in detecting high-grade gliomas: a systematic review and meta-analysis","volume":"13","author":"Castello","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"983023","DOI":"10.3389\/fonc.2023.983023","article-title":"An overview of radiolabeled amino acid tracers in oncologic imaging","volume":"13","author":"Jain","year":"2023","journal-title":"Front Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.mam.2013.01.001","article-title":"The SLC1 high-affinity glutamate and neutral amino acid transporter family","volume":"34","author":"Kanai","year":"2013","journal-title":"Mol Aspects Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0021-5198(19)36913-6","article-title":"Cloning and characterization of a system ASC-like NA\u207a-dependent neutral amino acid transporter","volume":"71","author":"Utsunomiya-Tate","year":"1996","journal-title":"Jpn J Pharmacol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.2967\/jnumed.107.040097","article-title":"Biodistribution and radiation dosimetry of the synthetic nonmetabolized amino acid analogue anti-18F-FACBC in humans","volume":"48","author":"Nye","year":"2007","journal-title":"J Nucl Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3389\/fcell.2018.00096","article-title":"The human SLC1A5 (ASCT2) amino acid transporter: from function to structure and role in cell biology","volume":"6","author":"Scalise","year":"2018","journal-title":"Front Cell Dev Biol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"104844","DOI":"10.1016\/j.phrs.2020.104844","article-title":"Target the human alanine\/serine\/cysteine transporter 2 (ASCT2): achievement and future for novel cancer therapy","volume":"158","author":"Jiang","year":"2020","journal-title":"Pharmacol Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s12149-025-02089-6","article-title":"Clinical practice guidelines for 18F-fluciclovine 2024 in the Japanese society of nuclear medicine","volume":"39","author":"Ito","year":"2025","journal-title":"Ann Nucl Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/BF02984466","article-title":"Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery\u2013in malignant glioma\u2013","volume":"18","author":"Tsuyuguchi","year":"2004","journal-title":"Ann Nucl Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"694","DOI":"10.2967\/jnumed.107.048082","article-title":"Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy","volume":"49","author":"Terakawa","year":"2008","journal-title":"J Nucl Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.22038\/aojnmb.2017.8843","article-title":"Diagnosis of brain tumors using amino acid transport PET imaging with 18F-fluciclovine: a comparative study with L-methyl-11C-methionine PET imaging","volume":"5","author":"Tsuyuguchi","year":"2017","journal-title":"Asia Ocean J Nucl Med Biol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s00259-019-04433-1","article-title":"18F-fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors","volume":"47","author":"Michaud","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B14","doi-asserted-by":"publisher","first-page":"822","DOI":"10.2967\/jnumed.110.086074","article-title":"Putative transport mechanism and intracellular fate of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid in human prostate cancer","volume":"52","author":"Okudaira","year":"2011","journal-title":"J Nucl Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.nucmedbio.2013.03.009","article-title":"Kinetic analyses of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid transport in Xenopus laevis oocytes expressing human ASCT2 and SNAT2","volume":"40","author":"Okudaira","year":"2013","journal-title":"Nucl Med Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s11307-013-0693-0","article-title":"Differences in transport mechanisms of trans-1-amino-3-[18F] fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[methyl-11C] methionine and 2-deoxy-2-[18F] fluoro-D-glucose","volume":"16","author":"Oka","year":"2014","journal-title":"Mol Imaging Biol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"829050","DOI":"10.3389\/fonc.2022.829050","article-title":"Imaging glioblastoma with 18F-fluciclovine amino acid positron emission tomography","volume":"12","author":"Scarpelli","year":"2022","journal-title":"Front Oncol"},{"key":"B18","first-page":"16","article-title":"L-methionine uptake by human cerebral cortex: maturation from infancy to old age","volume":"32","author":"O\u2019Tuama","year":"1991","journal-title":"J Nucl Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2967\/jnumed.109.068783","article-title":"Evaluation of the accumulation of 11C-methionine with standardized uptake value in the normal brain","volume":"51","author":"Uda","year":"2010","journal-title":"J Nucl Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.5334\/jbr-btr.892","article-title":"Assessment of pineal gland volume and calcification in healthy subjects: is it related to aging?","volume":"100","author":"Beker-Acay","year":"2016","journal-title":"J Belg Soc Radiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13643-023-02205-5","article-title":"Prevalence of pineal gland calcification: systematic review and meta-analysis","volume":"12","author":"Belay","year":"2023","journal-title":"Syst Rev"},{"key":"B22","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1053\/j.semnuclmed.2021.06.016","article-title":"PET\/CT variants and pitfalls in prostate cancer: what you might see on PET and should never forget","volume":"51","author":"Mei","year":"2021","journal-title":"Semin Nucl Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00259-019-04614-y","article-title":"[18F] fluciclovine PET\/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging-version 1.0","volume":"47","author":"Nanni","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1093\/rheumatology\/keaa624","article-title":"Advanced imaging for quantification of abnormalities in the salivary glands of patients with primary Sj\u00f6gren's Syndrome","volume":"60","author":"Jimenez-Royo","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2214\/AJR.19.21894","article-title":"Extraprostatic uptake of 18F-fluciclovine: differentiation of nonprostatic neoplasms from metastatic prostate cancer","volume":"214","author":"Robertson","year":"2020","journal-title":"AJR Am J Roentgenol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1929565","DOI":"10.1155\/2020\/1929565","article-title":"Understanding and improving 18F-fluciclovine PET\/CT reports: a guide for physicians treating patients with biochemical recurrence of prostate cancer","volume":"2020","author":"Lowentritt","year":"2020","journal-title":"Prostate Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s00259-012-2291-9","article-title":"Regional distribution and kinetics of [18F] fluciclovine (anti-[18F] FACBC), a tracer of amino acid transport, in subjects with primary prostate cancer","volume":"40","author":"S\u00f6rensen","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B28","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s12149-011-0477-z","article-title":"Phase I clinical study of NMK36: a new PET tracer with the synthetic amino acid analogue anti-[18F] FACBC","volume":"25","author":"Asano","year":"2011","journal-title":"Ann Nucl Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1097\/RLU.0000000000001789","article-title":"Recurrent malignant melanoma detected on 18F-fluciclovine PET\/CT imaging for prostate cancer","volume":"42","author":"Teoh","year":"2017","journal-title":"Clin Nucl Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.wneu.2018.07.231","article-title":"Fluciclovine, anti-1-amino-3-[18F]-fluorocyclobutane-1-carboxylic acid: a novel radiotracer for meningioma","volume":"119","author":"Nguyen","year":"2018","journal-title":"World Neurosurg"},{"key":"B31","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2967\/jnumed.117.204032","article-title":"Update on 18F-fluciclovine PET for prostate cancer imaging","volume":"59","author":"Parent","year":"2018","journal-title":"J Nucl Med"}],"container-title":["Frontiers in Nuclear Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnume.2026.1850254\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:42:45Z","timestamp":1780378965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnume.2026.1850254\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":31,"alternative-id":["10.3389\/fnume.2026.1850254"],"URL":"https:\/\/doi.org\/10.3389\/fnume.2026.1850254","relation":{},"ISSN":["2673-8880"],"issn-type":[{"value":"2673-8880","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"article-number":"1850254"}}